Shirakawa, T., Furukawa, J., Kakei, Y., Ueki, H., Hara, T., Teishima, J., Hinata, N., Miyake, H., Fujisawa, M. (2025). A phase 1, first-in-human, open label, dose escalating study of B440, an oral cancer vaccine using a WT1-expressing Bifidobacterium , in patients with advanced urothelial cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.tps883